NEW YORK (GenomeWeb News) — Bioconjugation product developer SoluLink today reported it has received $300,000 in venture capital from Plymouth Venture Partners.
 
SoluLink President Steve DeGraw said the investment will enable the company to continue marketing existing products, and to integrate them into new markets.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.